Vanda Bets Big on Solving GLP-1’s Biggest Problem:...
Category : Clinical Trial Update 11 April 2026GLP-1 drugs are winning. Patient adherence is not. That gap is where Vanda Pharmaceuticals is placin...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
PharmaSens Unveils First All-in-One Insulin Patch...
Category : Clinical Trial Update 11 April 2026Diabetes tech is powerful—but still too complicated. Multiple devices. Connectivity issues. Hi...
MetaVia Advances Next-Gen Obesity Drug DA-1726 Int...
Category : Clinical Trial Update 11 April 2026The GLP-1 race is evolving—and the next wave is already here. MetaVia Inc. has dosed the first...
Merck Moves to Acquire Terns Pharmaceuticals: A Ca...
Category : Merger/Acquisition 10 April 2026Global pharma giant Merck & Co. has officially set its acquisition plan in motion. The company h...
GSK Expands Exdensur’s Reach in China: A New Optio...
Category : Approval/Launch 10 April 2026Global biopharma leader GSK plc has secured another regulatory win in China. China’s Nation...
Latest Newsletter Post
-
MetaVia Advances Next-Gen Obesity D..
11 April 2026
-
PharmaSens Unveils First All-in-One..
11 April 2026
-
Vanda Bets Big on Solving GLP-1’s B..
11 April 2026
-
Revision Skincare Publishes Clinica..
10 April 2026
-
GSK Expands Exdensur’s Reach in Chi..
10 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com